Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Drug Dissolution: Alternative Methods01:17

In Vitro Drug Dissolution: Alternative Methods

Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
Theories of Dissolution: Diffusion Layer Model01:15

Theories of Dissolution: Diffusion Layer Model

Dissolution, the process by which drug particles dissolve in a solvent, is explained by the diffusion layer model, a theoretical framework that simulates the absorption of oral drugs and allows us to analyze experimental data.
This process starts with a thin layer, saturated with the drug, forming at the interface between the solid and liquid. The solute then diffuses from this layer into the main solution. The Noyes-Whitney equation suggests that the rate of dissolution relies on the diffusion...
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RobInHood: a robotic chemist in a fume hood.

Digital discovery·2026
Same author

CiteSource: An R package for data-driven search strategy development and enhanced evidence synthesis reporting.

Research synthesis methods·2026
Same author

Fluid-Attenuated Inversion Recovery Correlates with Stroke Onset in Childhood Arterial Ischemic Stroke.

AJNR. American journal of neuroradiology·2026
Same author

A Standardized Definition of Rapid Evidence Assessment for Environmental Applications.

Conservation letters·2026
Same author

The impact of parental socioeconomic characteristics and engagement on children's early academic abilities: the role of racial and economic disparities.

Frontiers in psychology·2026
Same author

Regulatory Considerations for Medical Aerosol Products.

Journal of aerosol medicine and pulmonary drug delivery·2026

Related Experiment Video

Updated: May 20, 2026

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

Challenges with developing in vitro dissolution tests for orally inhaled products (OIPs).

Trevor Riley1, David Christopher, Jan Arp

  • 1Inhaled Product & Device Technology, GlaxoSmithKline, Hertfordshire, UK.

AAPS Pharmscitech
|July 17, 2012
PubMed
Summary

Current dissolution testing methods for orally inhaled products (OIPs) lack sufficient data for quality and efficacy assessment. Standardization for compendial use is premature due to insufficient evidence of clinical relevance.

More Related Videos

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

In vitro Digestion of Emulsions in a Single Droplet via Multi Subphase Exchange of Simulated Gastrointestinal Fluids
10:20

In vitro Digestion of Emulsions in a Single Droplet via Multi Subphase Exchange of Simulated Gastrointestinal Fluids

Published on: November 18, 2022

Related Experiment Videos

Last Updated: May 20, 2026

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
06:09

Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates

Published on: May 30, 2025

In vitro Digestion of Emulsions in a Single Droplet via Multi Subphase Exchange of Simulated Gastrointestinal Fluids
10:20

In vitro Digestion of Emulsions in a Single Droplet via Multi Subphase Exchange of Simulated Gastrointestinal Fluids

Published on: November 18, 2022

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery
  • Analytical Chemistry

Background:

  • Orally inhaled products (OIPs) require methods to assess particle dissolution.
  • Existing analytical techniques for OIPs include USP 2, flow-through cell, and diffusion cell apparatus.
  • Modified-release formulations may benefit from these dissolution techniques.

Purpose of the Study:

  • To review the suitability of analytical and statistical techniques for assessing OIP particle dissolution.
  • To evaluate techniques for particles in the respirable aerodynamic size range.
  • To determine if current data supports quality, performance, safety, or efficacy claims for OIPs.

Main Methods:

  • Comprehensive literature review of analytical techniques for OIP dissolution.
  • Analysis of methods including paddle-over-disk USP 2, flow-through cell, and diffusion cell apparatus.
  • Evaluation of the strengths and weaknesses of each technique.

Main Results:

  • Current analytical techniques have research value, particularly for modified-release formulations.
  • Insufficient knowledge exists to translate dissolution data into quality, performance, safety, or efficacy statements for OIPs.
  • Standardization for compendial inclusion is deemed premature based on existing evidence.

Conclusions:

  • The choice of dissolution method should align with specific research questions and technique limitations.
  • Further research is needed to establish the clinical relevance of OIP dissolution testing.
  • Current evidence does not support the routine compendial use of dissolution testing for OIPs.